May 29, 2019
Rose
Patients who are undergoing immunotherapy are developing a disease akin to type 1 diabetes. “If I knew then, when I opted for the clinical trial, what type 1 diabetes entailed, I would never have gone for the immunotherapy. Never. I would have taken the chance of the cancer coming back,” said Jaime Vidal, 79, a retired mailman from San Bruno, Calif. In other pharmaceutical news: accelerated approvals for cancer drugs, troubling manufacturing problems and the right-to-try bill.
from Kaiser Health News http://bit.ly/2VXASec
May 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: Washington State Lawmaker Angers Rural Nurses, Saying They Probably Play Cards; 10 Mass. Health Systems Become Partners, Save Millions- As U.S. Population Ages, Hospitals Begin Creating Emergency Rooms Designed To Better Suit Older Patients’ Unique Needs
- Researchers Begin To Dig Into Health Risks Of A Common Group Of Chemicals Found In Environment, Humans
- The Flu Season That Just Won’t End: Second Viral Wave Is Pushing Otherwise Mild Year Into The Record Books
- Viewpoints: If Only U.S. Health Policy Was This Good; Why Didn’t People Care About Opioid Epidemic Until It Hit White, Middle-Class America?
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment